Making Patient Safety a Priority

A survey examining consumer opinions on counterfeit drugs across Europe carried out by ICM research on behalf of Aegate this month, confirmed that proposed measures under the European Commission's pharmaceutical package on counterfeit medicines will bring consumer confidence.

See more

About Us

Patient safety communications company Aegate provides:

  • Real-time authentication
  • Delivers up-to-the minute safety information

whilst the pharmacist is dispensing to the patient.

Read More


News

News

Medicines top counterfeit concern list in Europe - consumers call for tougher safety measures more

Study validates benefits of drug authentication more

Aegate launches traceability service, extending drug authentication to the distribution chain more

Full news archive